|Day Low/High||5.12 / 5.35|
|52 Wk Low/High||2.50 / 14.84|
Noble Capital Markets, a leading small-cap focused investment firm, announces the initiation of research coverage of Anavex Life Sciences.
TheStreet's biotech columnist offers his own report card on biotech stocks.
Investors in Anavex Life Sciences Corp saw new options begin trading this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVXL options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.
Biotechs were trading at high volumes Thursday morning on news that the Senate has passed the 21st Century Cures Act.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
I stopped out of Lantheus Holdings for a small loss and bought Baozun near $15.
Preclinical Data for ANAVEX 1066 Presented at Society for Neuroscience Annual Meeting
The most recent short interest data has been released for the 10/14/2016 settlement date, which shows a 883,721 share increase in total short interest for Anavex Life Sciences Corp , to 5,641,528, an increase of 18.57% since 09/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
These under-$10 stocks are within range of triggering breakout trades. Here's how to trade them from here.
Here's a technical look at how to trade some of the most active stocks on the market right now.
Anavex (AVXL) announced on Thursday its Anavex 2-73 Parkinson's treatment was successful in a preclinical study.
Michael J. Fox Foundation funded ANAVEX 2-73 drug candidate study presented at World Parkinson Congress 2016
Conference to Feature Companies with Focus on Alzheimer's, Parkinson's and other Neurological Diseases
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Anavex Life Sciences Corp , where a total volume of 10,707 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 90.4% of AVXL's average daily trading volume over the past month, of 1.2 million shares.